Axsome Therapeutics, Inc. Common Stock logo

Axsome Therapeutics, Inc. Common Stock (AXSM) Technical Analysis

$207.78-3.03%

Market is closed - opens 7 PM, 21 Sep 2026

Insights

  • Axsome Therapeutics Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Axsome Therapeutics Inc. stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Axsome Therapeutics Inc. stock is in a downtrend↘️
  • Based on analysis of the Pivot Points, the current market trend for Axsome Therapeutics Inc. stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
46.26
Neutral
Stochastic
32.94, 43.88
Neutral
Ultimate Oscillator
44.75
Neutral
Stochastic Relative Strength Index
64.58, 62.4
Neutral
Moving Average Convergence Divergence
-1.4, -2.45
Neutral

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
211.17
Buy
20
208.12
Sell
50
217.87
Sell

Exponential Moving Average

Period (Days)

Value

Action

10
210.59
Sell
20
210.91
Sell
50
215.87
Sell

Volume Weighted Moving Average

Period (Days)

Value

Action

10
212.56
Neutral
20
209.23
Neutral
50
218.91
Sell

Double Exponential Moving Average

Period (Days)

Value

Action

10
211.2
Buy
20
208.45
Sell
50
210.68
Sell

Triple Exponential Moving Average

Period (Days)

Value

Action

10
211.64
Buy
20
211.13
Buy
50
203.56
Sell

Pivot

Pivot

Value

Resistance L3
225.46
Resistance L2
220.97
Resistance L1
217.62
Pivot Point
213.13
Support L1
209.78
Support L2
205.29
Support L3
201.95

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.